| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3361035 | International Journal of Antimicrobial Agents | 2007 | 6 Pages |
Abstract
Antibiotic prophylaxis has been used for several decades to prevent infection in chemotherapy-induced neutropenia and its benefits have been debated just as long. Recent analysis suggests that quinolones may actually be life saving in high-risk groups such as acute leukaemia and autologous bone marrow transplant but these benefits are likely to be negated in the long term by the development of quinolone resistance.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Claudio Viscoli,